| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |